Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease

Area of Science:

• Developmental Biology
• Hepatology
• Metabolic Disorders

Background:

• Nonalcoholic fatty liver disease (NAFLD) is a widespread epidemic affecting both children and adults.
• Evidence suggests that the origins of NAFLD may be linked to fetal development and maternal environment.
• Developmental programming highlights how the maternal environment influences fetal development, impacting future disease risk.

Purpose of the Study:

• To investigate the role of maternal obesity in fetal liver development and its contribution to NAFLD risk.
• To explore the mechanisms by which the in utero environment alters hepatic function and predisposes to NAFLD.

Main Methods:

• Review of human and nonhuman primate studies focusing on maternal obesity and its effects on fetal development.
• Analysis of pathological mechanisms in NAFLD, particularly altered mitochondrial function and insulin resistance.
• Comparison of fetal and adult liver metabolic characteristics.

Main Results:

• Maternal obesity in utero establishes risk factors for pediatric obesity and NAFLD.
• Excess maternal fuel exposure alters fetal hepatic fatty acid oxidation, lipogenesis, and mitochondrial health.
• These alterations promote oxidative stress, triglyceride storage, and immune/epigenetic changes, priming the fetal liver for NAFLD.

Conclusions:

• The fetal liver's unique metabolic state is susceptible to alterations from maternal obesity.
• Developmental programming in utero significantly primes the fetal liver for NAFLD and potentially nonalcoholic steatohepatitis.
• Understanding these early-life mechanisms is crucial for preventing NAFLD in subsequent generations.